Superoxide in AVF dysfunction: A new target for intervention

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 12, 2012, Pages

  Zarjou, Abolfazl ^a   Agarwal, Anupam ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; DIHYDROBIOPTERIN; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; NITRIC OXIDE SYNTHASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; CONTROLLED STUDY; EDITORIAL; ENZYME ACTIVITY; INFLAMMATION; KIDNEY ARTERIOVENOUS FISTULA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 84871272715     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00549.2012     Document Type: Editorial

References (16)

1. Croatt AJ, Grande JP, Hernandez MC, Ackerman AW, Katusic ZS, Nath KA. Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME. Am J Pathol 176: 2530-2541, 2010.
2. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 7: 523-535, 1996.
3. Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459: 923-939, 2010.
4. Jeremy JY, Yim AP, Wan S, Angelini GD. Oxidative stress, nitric oxide, and vascular disease. J Card Surg 17: 324-327, 2002.
5. Johnson MS, McLennan G, Lalka SG, Whitfield RM, Dreesen RG. The porcine hemodialysis access model. J Vasc Interv Radiol 12: 969-977, 2001.
6. Juncos JP, Tracz MJ, Croatt AJ, Grande JP, Ackerman AW, Katusic ZS, Nath KA. Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int 74: 47-51, 2008.
7. Kelly BS, Heffelfinger SC, Whiting JF, Miller MA, Reaves A, Armstrong J, Narayana A, Roy-Chaudhury P. Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int 62: 2272-2280, 2002.
8. Lin CC, Yang WC, Lin SJ, Chen TW, Lee WS, Chang CF, Lee PC, Lee SD, Su TS, Fann CS, Chung MY. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 69: 165-172, 2006.
9. Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol 2: 1043-1053, 2007.
10. Roy-Chaudhury P, Kelly BS, Narayana A, Desai P, Melhem M, Munda R, Duncan H, Heffelfinger SC. Hemodialysis vascular access dysfunction from basic biology to clinical intervention. Adv Ren Replace Ther 9: 74-84, 2002.
11. Roy-Chaudhury P, Kelly BS, Zhang J, Narayana A, Desai P, Melham M, Duncan H, Heffelfinger SC. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif 21: 99-110, 2003.
12. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112-1127, 2006.
13. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122: 339-352, 2004.
14. Tracz MJ, Alam J, Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol 18: 414-420, 2007.
15. Tsapenko MV, d'Uscio LV, Grande JP, Croatt AJ, Hernandez MC, Ackerman AW, Katusic ZS, Nath KA. Increased production of superoxide anion contributes to dysfunction of the arteriovenous fistula. Am J Physiol Renal Physiol (First published September 19, 2012). doi:10.1152/ ajprenal.00449.2012.
16. Vazquez MA. Vascular access for dialysis: recent lessons and new insights. Curr Opin Nephrol Hypertens 18: 116-121, 2009.